Status:
COMPLETED
The Effect of Pomegranate Juice on Oxidative Stress in Hemodialysis Patients
Lead Sponsor:
Western Galilee Hospital-Nahariya
Conditions:
End Stage Renal Disease
Hemodialysis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Pomegranate juice (PJ) consumption by hemodialysis patients will reduce the oxidative stress and the incidence of infections, cardiovascular events and mortality.
Detailed Description
The mortality rate in patients with end stage renal failure is substantially higher than in the general population, and deaths are mainly attributable to cardiovascular diseases and infections. There ...
Eligibility Criteria
Inclusion
- End Stage Renal Disease, stable chronic hemodialysis \> 3 months
- Informed Consent.
- Man and women over 18 years.
Exclusion
- Hemodialysis \< 3 months
- Participation in other clinical trial
- Not eligible according to physician decision
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
End Date :
January 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00727519
Start Date
July 1 2008
End Date
January 1 2010
Last Update
March 23 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Western Galilee hospital
Nahariya, Israel, Israel, 22100